eli lilly tirzepatide fda approval Lilly's gained in December 2024 for treating moderate-to-severe obstructive sleep apnea in adults with obesity, after Phase III trials showed a 20% average weight loss and a roughly Lilly releases Zepbound® (tirzepatide) single-dose

Always carrying an extra pen and new needles with you, in case of loss or damage

When flying, keep compounded semaglutide in your carry-on bag so you can better control the temperature

If you frequently struggle with adherence, discuss this openly with your GP or diabetes specialist nurse, as they may suggest strategies tailored to your lifestyle or consider whether alternative treatment regimens might be more suitable for your circumstances

The SUMMIT trial demonstrated that tirzepatide significantly reduced the risk of HF hospitalisation or an urgent visit requiring intravenous diuretics

Roos DH, Seeger RL, Puntel RL, Barbosa NV (2012b) Role of calcium and mitochondria in MeHg-mediated cytotoxicity